Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in three segments: Nurse and Allied Staffing, Physician Staffing, and Search. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing; short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and travel allied professionals on long-term contract assignments, as well as workforce solutions, including MSP, OWS, RPO, IRP, EMR, and consulting services. It serves public and private acute care and non-acute care hospitals, government facilities, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, retailers, and other healthcare providers under the Cross Country brand. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The Search segment offers retained and contingent search services for physicians, healthcare executives, and other healthcare professionals, as well as recruitment process outsourcing. The company was founded in 1986 and is headquartered in Boca Raton, Florida.
IPO Year: 2001
Exchange: NASDAQ
Website: crosscountryhealthcare.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/6/2023 | Mkt Perform | JMP Securities | |
| 11/3/2023 | $32.00 → $21.00 | Buy → Hold | Jefferies |
| 6/26/2023 | Outperform | William Blair | |
| 3/10/2023 | $30.00 | Buy | Loop Capital |
| 10/5/2022 | $36.00 | Buy → Hold | Truist |
| 2/24/2022 | $33.00 → $42.00 | Buy | Benchmark |
| 1/27/2022 | $18.00 → $27.00 | Hold → Buy | Jefferies |
| 8/16/2021 | $13.50 → $19.00 | Neutral | Credit Suisse |
| 8/5/2021 | $22.00 | Hold → Buy | Benchmark |
| 8/5/2021 | $22.00 | Hold → Buy | The Benchmark Company |
10-Q - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
10-Q - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13G - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13G - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13G - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13G - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13D/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13D - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
JMP Securities initiated coverage of Cross Country with a rating of Mkt Perform
Jefferies downgraded Cross Country from Buy to Hold and set a new price target of $21.00 from $32.00 previously
William Blair initiated coverage of Cross Country with a rating of Outperform
Loop Capital initiated coverage of Cross Country with a rating of Buy and set a new price target of $30.00
Truist downgraded Cross Country from Buy to Hold and set a new price target of $36.00
Benchmark reiterated coverage of Cross Country Healthcare with a rating of Buy and set a new price target of $42.00 from $33.00 previously
Jefferies upgraded Cross Country Healthcare from Hold to Buy and set a new price target of $27.00 from $18.00 previously
Credit Suisse reiterated coverage of Cross Country Healthcare with a rating of Neutral and set a new price target of $19.00 from $13.50 previously
Benchmark upgraded Cross Country Healthcare from Hold to Buy and set a new price target of $22.00
The Benchmark Company upgraded Cross Country from Hold to Buy and set a new price target of $22.00
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) announced today that it is scheduled to participate in the UBS Global Healthcare Conference taking place November 11-14, 2024 at the Terranea Resort Hotel in Rancho Palos Verdes, CA. John Martins, President & Chief Executive Officer and Josh Vogel, Vice President, Investor Relations will participate in one-on-one investor meetings on Wednesday, November 13. No formal presentation will be made. About Cross Country Healthcare Cross Country Healthcare, Inc. is a market-leading, tech-enabled workforce solutions and advisory firm with 38 years of industry experience and insight. We help clients tackle complex labor-related challenges
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its third quarter 2024 financial results on Wednesday, November 6, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, November 6, 2024. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from November 6th through November 20th on the Company's website and a replay of the
NEW YORK, Sept. 26, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 and S&P MidCap 400: S&P SmallCap 600 constituent The Ensign Group Inc. (NASD: ENSG) will replace Southwestern Energy Co. (NYSE:SWN) in the S&P MidCap 400 and TransMedics Group, Inc. (NASD: TMDX) will replace The Ensign Group in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, October 1. S&P MidCap 400 constituent Chesapeake Energy Corp. (NASD: CHK) is acquiring Southwestern Energy in a deal expected to be completed October 1.Curbline Properties Corp. (NYSE:CURB) will be added to the S&P SmallCap 600 effective prior to the open of trading on Tuesda
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) announced today that it is scheduled to participate in two upcoming conferences: The Morgan Stanley 22nd Annual Global Healthcare Conference taking place September 4-6, 2024 at the Marriott Marquis in New York City. John Martins, President & Chief Executive Officer and Josh Vogel, Vice President, Investor Relations, will participate in one-on-one investor meetings on Thursday, September 5. No formal presentation will be made. The 17th Annual Barrington Research Virtual Fall Investment Conference taking place September 12, 2024. William J. Burns, Executive Vice President & Chief Financial Officer and Josh Vogel, Vice Presiden
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) today announced financial results for its second quarter ended June 30, 2024. SELECTED FINANCIAL INFORMATION: Variance Variance Q2 2024 vs Q2 2024 vs Dollars are in thousands, except per share amounts Q2 2024 Q2 2023 Q1 2024 Revenue $ 339,771 (37 ) % (10 ) % Gross profit margin* 20.8 % (200 ) bps 40 bps Net (loss) income attributable to common stockh
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its second quarter 2024 financial results on Wednesday, July 31, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, July 31, 2024. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from July 31st through August 14th on the Company's website and a replay of the conferen
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) announced today that it is scheduled to participate in the Citizens JMP Medical Devices and Healthcare Services Forum taking place June 20, 2024 at the Boston Harbor Hotel. John Martins, President & Chief Executive Officer and Josh Vogel, Vice President, Investor Relations, will participate in one-on-one investor meetings. No formal presentation will be made. About Cross Country Healthcare Cross Country Healthcare, Inc. is a market-leading, tech-enabled workforce solutions and advisory firm with 38 years of industry experience and insight. We help clients tackle complex labor-related challenges and achieve high-quality outcome
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) announced today that it is scheduled to participate in two upcoming conferences: The William Blair 44th Annual Growth Stock Conference taking place June 4-6, 2024 at the Loews Chicago Hotel. John Martins, President & Chief Executive Officer and Josh Vogel, Vice President, Investor Relations, will participate in one-on-one investor meetings on Tuesday, June 4. They will also participate in a formal presentation on Tuesday, June 4, 2024 from 11:20 a.m. to 11:50 a.m. Central Time. An audio webcast for this conference will be available on the Company's website at ir.crosscountry.com in the Investor Relations section under ‘Events a
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) announced today that it is scheduled to participate in Benchmark's Healthcare House Call Virtual One-on-One Investor Conference taking place May 21-22, 2024. William J. Burns, Executive Vice President & Chief Financial Officer and Josh Vogel, Vice President, Investor Relations, will participate in virtual one-on-one investor meetings on Wednesday, May 22, 2024. No formal presentation will be made. About Cross Country Healthcare Cross Country Healthcare, Inc. is a market-leading, tech-enabled workforce solutions and advisory firm with 38 years of industry experience and insight. We help clients tackle complex labor-related chal
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) today announced financial results for its first quarter ended March 31, 2024. SELECTED FINANCIAL INFORMATION: Variance Variance Q1 2024 vs Q1 2024 vs Dollars are in thousands, except per share amounts Q1 2024 Q1 2023 Q4 2023 Revenue $ 379,174 (39) % (8) % Gross profit margin* 20.4 % (200) bps (150) bps Net income attributable to common stockholders $ 2,692 (
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
Barrington Research analyst Kevin Steinke maintains Cross Country Healthcare (NASDAQ:CCRN) with a Outperform and lowers the price target from $24 to $21.
Throughout the last three months, 4 analysts have evaluated Cross Country Healthcare (NASDAQ:CCRN), offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 1 1 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 1 1 0 0 Insights from analysts' 12-month price targets are revealed, presenting an average target of $20.0, a high estimate of $24.00, and a low estimate of $16.00. This current average has decrease
Benchmark analyst Bill Sutherland maintains Cross Country Healthcare (NASDAQ:CCRN) with a Buy and lowers the price target from $21 to $19.
Cross Country Healthcare (NASDAQ:CCRN) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.17 by 11.76 percent. This is a 77.38 percent decrease over earnings of $0.84 per share from the same period last year. The company reported quarterly sales of $379.174 million which beat the analyst consensus estimate of $374.089 million by 1.36 percent. This is a 39.11 percent decrease over sales of $622.707 million the same period last year.
Barrington Research analyst Kevin Steinke maintains Cross Country Healthcare (NASDAQ:CCRN) with a Outperform and lowers the price target from $26 to $24.
4 analysts have expressed a variety of opinions on Cross Country Healthcare (NASDAQ:CCRN) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 1 2 0 0 Last 30D 1 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 1 1 0 0 Analysts have recently evaluated Cross Country Healthcare and provided 12-month price targets. The average target is $21.25, accompanied by a high estimate of $26.00 and a low estimate of $16.00. Thi
Truist Securities analyst Tobey Sommer maintains Cross Country Healthcare (NASDAQ:CCRN) with a Hold and lowers the price target from $22 to $16.
Benchmark analyst Bill Sutherland maintains Cross Country Healthcare (NASDAQ:CCRN) with a Buy and lowers the price target from $24 to $21.
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its third quarter 2024 financial results on Wednesday, November 6, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, November 6, 2024. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from November 6th through November 20th on the Company's website and a replay of the
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) today announced financial results for its second quarter ended June 30, 2024. SELECTED FINANCIAL INFORMATION: Variance Variance Q2 2024 vs Q2 2024 vs Dollars are in thousands, except per share amounts Q2 2024 Q2 2023 Q1 2024 Revenue $ 339,771 (37 ) % (10 ) % Gross profit margin* 20.8 % (200 ) bps 40 bps Net (loss) income attributable to common stockh
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its second quarter 2024 financial results on Wednesday, July 31, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, July 31, 2024. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from July 31st through August 14th on the Company's website and a replay of the conferen
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) today announced financial results for its first quarter ended March 31, 2024. SELECTED FINANCIAL INFORMATION: Variance Variance Q1 2024 vs Q1 2024 vs Dollars are in thousands, except per share amounts Q1 2024 Q1 2023 Q4 2023 Revenue $ 379,174 (39) % (8) % Gross profit margin* 20.4 % (200) bps (150) bps Net income attributable to common stockholders $ 2,692 (
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its first quarter 2024 financial results on Wednesday, May 1, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, May 1, 2024. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from May 1st through May 15th on the Company's website and a replay of the conference call wi
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its fourth quarter and full year 2023 financial results on Wednesday, February 21, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, February 21, 2024. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from February 21st through March 6th on the Company's website and
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its third quarter 2023 financial results on Wednesday, November 1, 2023 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, November 1, 2023. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from November 1st through November 15th at the Company's website and a replay of th
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its second quarter 2023 financial results on Wednesday, August 2, 2023 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, August 2, 2023. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from August 2nd through August 16th at the Company's website and a replay of the confe
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its first quarter 2023 financial results on Wednesday, May 3, 2023 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, May 3, 2023. This call will be webcast live and can be accessed at the Company's website at ir.crosscountryhealthcare.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from May 3rd through May 17th at the Company's website and a replay of the conferen
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2022. SELECTED FINANCIAL INFORMATION: Dollars are in thousands, except per share amounts Q4 2022 Variance Q4 2022 vs Q4 2021 Variance Q4 2022 vs Q3 2022 Full Year 2022 Variance 2022 vs 2021 Revenue $ 628,218 (2 ) % (1 ) % $ 2,806,609 67 % Gross profit margin* 22.1 % (90 ) bps (50 ) bps 22.4 % — bps Net income attributable to common stockholders $ 38,791 (50 )
NEW YORK, Sept. 26, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 and S&P MidCap 400: S&P SmallCap 600 constituent The Ensign Group Inc. (NASD: ENSG) will replace Southwestern Energy Co. (NYSE:SWN) in the S&P MidCap 400 and TransMedics Group, Inc. (NASD: TMDX) will replace The Ensign Group in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, October 1. S&P MidCap 400 constituent Chesapeake Energy Corp. (NASD: CHK) is acquiring Southwestern Energy in a deal expected to be completed October 1.Curbline Properties Corp. (NYSE:CURB) will be added to the S&P SmallCap 600 effective prior to the open of trading on Tuesda
Cross Country Healthcare, Inc., (NASDAQ:CCRN), a leading provider of advisory and workforce solutions including contingent staffing, permanent placement, and other consultative services for healthcare clients, has appointed Phillip Noe to the role of Chief Information Officer (CIO). Noe replaces Bill Halnon who is retiring, and will report directly to Kevin C. Clark, Co-founder and CEO. He commences May 10, 2021. "Phil's appointment reflects the ongoing evolution of our digital transformation at Cross Country," said Kevin C. Clark, Co-founder and Chief Executive Officer of Cross Country Healthcare. "His extensive experience in information technology spans every aspect of the software engin